TG Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
AbbVie USD -1490000000 5.32B 2024-12
Alaunos Therapeutics USD -1150000 16K 2024-09
Amgen USD 2.31B 182M 2024-12
Ardelyx USD 8.12M 5.89M 2024-12
Arrowhead Research USD -161412000 791K 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Biogen USD 441.4M 24.4M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Dynavax Technologies USD -1632000 11.71M 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
J&J USD 3.89B 549M 2024-12
Novartis USD 2.28B 1.34B 2024-12
PTC Therapeutics USD -62489000 7.98M 2024-12
Regeneron Pharmaceuticals USD 990.2M 189.3M 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
TG Therapeutics USD 29.95M 17.52M 2024-12
Vertex Pharmaceuticals USD 1.03B 90.3M 2024-12



TG Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.